0001127602-14-010742.txt : 20140307 0001127602-14-010742.hdr.sgml : 20140307 20140307171909 ACCESSION NUMBER: 0001127602-14-010742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140306 FILED AS OF DATE: 20140307 DATE AS OF CHANGE: 20140307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 OAK PARK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-5000 MAIL ADDRESS: STREET 1: 9 OAK PARK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wielinski Tracey Haas CENTRAL INDEX KEY: 0001600891 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 14678310 MAIL ADDRESS: STREET 1: C/O INSULET CORPORATION STREET 2: 9 OAK PARK DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2014-03-06 0001145197 INSULET CORP PODD 0001600891 Wielinski Tracey Haas C/O INSULET CORPORATION 9 OAK PARK DRIVE BEDFORD MA 01730 1 VP, Global Regulatory, CA, QA Common Stock 2014-03-06 4 M 0 5000 23.27 A 32275 D Common Stock 2014-03-06 4 S 0 7275 49.1021 D 25000 D Common Stock 2014-03-06 4 S 0 1000 49.98 D 24000 D Employee Stock Option (Right to Buy) 23.27 2014-03-06 4 M 0 5000 0 D 2023-02-01 Common Stock 5000 15000 D Includes 15,000 restricted stock units granted on February 1, 2013, which vest one-third of the total units on February 1, 2015, one-third of the total units on February 1, 2016 and one-third of the total units on February 1, 2017, subject to continued employment; and 9,000 restricted stock units granted on March 3, 2014 which vest one-third of the total units on March 3, 2015, one-third of the total units on March 3, 2016, and one-third of the total units on March 3, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2013. The price reported represents the weighted average sales price of the shares sold. The shares were sold at varying prices in the range of $48.60 to $49.64. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. /s/ R. Anthony Diehl, attorney in fact 2014-03-07